We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Poster: ALL-071: A Phase 4 Study to Evaluate Outpatient Blinatumomab in Patients with Minimal/Measurable Residual Disease (MRD) Positivity (+) of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL).
- Authors
Khan, Sharif S.; Mori, Shahram; Jeyakumar, Deepa; Keng, Michael Kenneth; Murthy, Hemant S.; Bar-Natan, Michal; Gundabolu, Krishna; O'Dwyer, Kristen; Rodriguez, Tulio; Stein, Anthony Selwyn; Oliai, Caspian; McCann, Christopher; Zaman, Faraz; Zugmaier, Gerhard; Gordon, Paul; Pardee, Timothy S.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2021, Vol 21, pS209
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/S2152-2650(21)01308-2